282 related articles for article (PubMed ID: 9703528)
1. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.
Bashford JN; Norwood J; Chapman SR
BMJ; 1998 Aug; 317(7156):452-6. PubMed ID: 9703528
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors: a study of GPs' prescribing.
Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
[TBL] [Abstract][Full Text] [Related]
3. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.
Martin RM; Dunn NR; Freemantle S; Shakir S
Br J Clin Pharmacol; 2000 Oct; 50(4):366-72. PubMed ID: 11012560
[TBL] [Abstract][Full Text] [Related]
4. Prescribing of proton-pump inhibitors: auditing the management and reasons for prescribing in Danish general practice.
Jarbøl DE; Lykkegaard J; Hansen JM; Munck A; Haastrup PF
Fam Pract; 2019 Nov; 36(6):758-764. PubMed ID: 31165863
[TBL] [Abstract][Full Text] [Related]
5. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate use of proton pump inhibitors.
Molloy D; Molloy A; O'Loughlin C; Falconer M; Hennessy M
Ir J Med Sci; 2010 Mar; 179(1):73-5. PubMed ID: 19763673
[TBL] [Abstract][Full Text] [Related]
7. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care.
Martin RM; Lim AG; Kerry SM; Hilton SR
Aliment Pharmacol Ther; 1998 Aug; 12(8):797-805. PubMed ID: 9726394
[TBL] [Abstract][Full Text] [Related]
8. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
9. Off-label use of proton pump inhibitors and P-blockers in general practices: an analysis using the Disease Analyzer--mediplus patient database.
Schröder-Bernhardi D; Roth K; Dietlein G
Int J Clin Pharmacol Ther; 2004 Nov; 42(11):581-8. PubMed ID: 15598023
[TBL] [Abstract][Full Text] [Related]
10. [Proton pump blockers and their significance in gastroenterology].
Dítĕ P; Prásek J
Vnitr Lek; 1995 Aug; 41(8):549-54. PubMed ID: 7483340
[TBL] [Abstract][Full Text] [Related]
11. [Lansoprazol ++ : a new proton pump inhibitor].
Baczek J; Laskowiec G
Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
[TBL] [Abstract][Full Text] [Related]
12. [Acid-related disease in the population of two Norwegian municipalities--diagnosis and drug therapy].
Vetvik K; Straand J
Tidsskr Nor Laegeforen; 2001 Feb; 121(5):557-62. PubMed ID: 11301609
[TBL] [Abstract][Full Text] [Related]
13. General Practice Research Database for prescribing analysis.
Frischer M; Chapman S; Bashford J; Norwood J; Heatlie H
Lancet; 1998 Feb; 351(9100):453-4. PubMed ID: 9482346
[No Abstract] [Full Text] [Related]
14. Lansoprazole: an update of its place in the management of acid-related disorders.
Matheson AJ; Jarvis B
Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors in general medicine. Comparison of routine practices with marketing authorization indications.
Levy-Neumand O; Carniaux F; Bonaz B; Durand A; Roblin X
Gastroenterol Clin Biol; 2007 Jan; 31(1):78-83. PubMed ID: 17273135
[TBL] [Abstract][Full Text] [Related]
16. General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study.
Haastrup PF; Rasmussen S; Hansen JM; Christensen RD; Søndergaard J; Jarbøl DE
BMC Fam Pract; 2016 May; 17():57. PubMed ID: 27233634
[TBL] [Abstract][Full Text] [Related]
17. Trends in prescribing volumes and costs of proton pump inhibitors in three outpatient specialties: a three-year retrospective study in a tertiary hospital in Thailand.
Yusof F; Sanguanhong S; Soorapan S; Pongwecharak J
Int J Pharm Pract; 2023 Mar; 31(1):80-85. PubMed ID: 36773006
[TBL] [Abstract][Full Text] [Related]
18. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
19. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
Craig DG; Thimappa R; Anand V; Sebastian S
QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
[TBL] [Abstract][Full Text] [Related]
20. Lansoprazole overutilization: methods for step-down therapy.
Pohland CJ; Scavnicky SA; Lasky SS; Good CB
Am J Manag Care; 2003 May; 9(5):353-8. PubMed ID: 12744297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
